NEW YORK (360DX) – Texas-based United Allergy Services filed suit against Quest Diagnostics late last month, accusing the lab giant of conspiring with other market players to eliminate lower-priced competition.

The allergy company alleges that Quest and co-conspirators have cost the company $200 million in lost profits. Specifically, the suit alleges that Quest and other players in the industry convinced insurers and potential UAS customers that doing business with UAS "caused medical, legal and other risks."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.